The need for contamination control in studies on lanthanum biodisposition  by Mcleod, Cameron et al.
Kidney International, Vol. 68 (2005), pp. 2906–2916
LETTERS TO THE EDITOR
The need for contamination
control in studies on
lanthanum biodisposition
To the Editor: Whereas published data on the biodispo-
sition of lanthanum should be welcomed, those reported
by Lacour et al [1] give cause for concern. Concentra-
tions of lanthanum in plasma for control samples were
of the order of 400 ng/mL, and values were not signif-
icantly elevated in rats given lanthanum carbonate. In
independent studies we, and others, have obtained back-
ground levels 1000 to 10,000 times lower and routinely
differentiate plasma from control and lanthanum-treated
groups (see Fig. 1) [2]. In dialysis patients treated with
recommended doses of Fosrenol, steady state plasma
concentrations are <1 ng/mL [3] (see also Prescribing In-
formation), 400 times lower than in the placebo samples
in the Lacour et al [1] rat study. These results strongly sug-
gest contamination of analytical samples with lanthanum
from the animals’ environment.
It is well known that trace/ultratrace element determi-
nations are subject to potential analyte contamination at
all stages in the sampling/analytical process and, in our
experience with lanthanum, stringent precautions must
be taken to avoid contamination. Lanthanum’s low oral
bioavailability (0.0007% in rats) results in excretion of al-
most all the dose via feces into the animal’s environment,
contaminating skin and fur. This situation demands rigor-
ous contamination control measures when handling ani-
mals, during blood and urine collection, and at autopsy,
to avoid the transfer of exogenous lanthanum into ana-
lytical samples. The potential problems of contamination
in rodent studies, especially dietary studies, have recently
attracted strong interest from drug regulatory authorities,
leading to issuance of new draft guidelines on the conduct
of animal safety studies [4].
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Fig. 1. Plasma lanthanum concentrations in rats given a single oral dose
of lanthanum carbonate (1500 mg/kg) or vehicle (control) by gavage.
Values are mean ± SD; N = 6; LLoQ (lower limit of quantification)
= 0.05 ng/mL; values <LLoQ reported as 0.05 ng/mL. Manuscript in
preparation.
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Reply from the Author
We thank McLeod et al for having drawn attention to
an error in Figure 3A of our article published in a recent
issue of Kidney International [1]. The unit of plasma lan-
thanum has been erroneously indicated as ‘lg/mL’ when
in fact it should read ‘lg/L,’ as shown by the scan of a
randomly selected original laboratory sheet of the lan-
thanum determinations done in our study (Fig. 1). We
sent an erratum to the Editors earlier this month when
we became aware of this regrettable typographic error.
The erratum was published in the July 2005 issue.
We agree that every possible precaution should be
taken to avoid contamination of plasma and tissue sam-
ples by trace elements when given in large amounts to
experimental animals or man. It is true that in our study,
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